Publisher Mary Ann Liebert, Inc., publishers has announced the appointment of Dr. Terry R. Flotte, Executive Deputy Chancellor, Provost, and Dean of the School of Medicine at University of Massachusetts Medical School, as the new incoming Editor-in-Chief of Human Gene Therapy, Human Gene Therapy Methods, and Human Gene Therapy Clinical Development, effective July 1, 2015. Dr. Flotte is currently an Associate Editor of the Journal.
Dr. Flotte will succeed Dr. James M. Wilson, Director of the Gene Therapy Program, Department of Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine, who has been Editor-in-Chief of the Journal since 2003.
Dr. Flotte is well known in the gene therapy community. He was the Principal Investigator for the first use of rAAV in humans, in cystic fibrosis trials beginning in 1995, leading to important early safety data and contributing important observations regarding molecular mechanisms of rAAV persistence and immune responses in humans. Dr. Flotte is the author of more than 230 scholarly papers, his published work has been cited close to 7,500 times, and his research has been continuously NIH funded for 22 years. The Flotte lab is currently investigating the delivery of therapeutic genes and microRNA with recombinant vectors for genetic diseases, such as alpha-1 antitrypsin (AAT) deficiency. Dr. Flotte serves on the Liaison Committee on Medical Education and the ASGCT Advisory Council, setting policy and goals for promoting gene therapy research through public education, scientific meetings, and scientific committees.
Alongside his leadership roles, Dr. Flotte has also continued his pediatric practice while pursuing clinical trials and basic laboratory research. Dr. Flotte has received numerous honors and awards, including the E. Mead Johnson award for outstanding scientific contributions from the Society of Pediatric Research in 2005, the Massachusetts Society for Medical Research Award for pioneering work in human gene therapy and his leadership in groundbreaking biomedical research in 2012. In 2013, he was inducted into the Johns Hopkins Society of Scholars.
The editorial transition will begin on May 1, 2015 and Dr. Flotte will take full helm of the Journal on July 1, 2015.